- Home
- BBIO vs OMC Comparison
BBIO vs OMC Comparison
Compare BBIO & OMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- OMC
- Stock Information
- Founded
- BBIO 2015
- OMC 1944
- Country
- BBIO United States
- OMC United States
- Employees
- BBIO N/A
- OMC N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- OMC Advertising
- Sector
- BBIO Health Care
- OMC Consumer Discretionary
- Exchange
- BBIO Nasdaq
- OMC Nasdaq
- Market Cap
- BBIO 12.5B
- OMC 14.9B
- IPO Year
- BBIO 2019
- OMC N/A
- Fundamental
- Price
- BBIO $71.90
- OMC $71.33
- Analyst Decision
- BBIO Strong Buy
- OMC Buy
- Analyst Count
- BBIO 19
- OMC 7
- Target Price
- BBIO $74.79
- OMC $96.57
- AVG Volume (30 Days)
- BBIO 2.4M
- OMC 3.8M
- Earning Date
- BBIO 10-29-2025
- OMC 10-21-2025
- Dividend Yield
- BBIO N/A
- OMC 3.92%
- EPS Growth
- BBIO N/A
- OMC N/A
- EPS
- BBIO N/A
- OMC 6.79
- Revenue
- BBIO $353,780,000.00
- OMC $16,065,300,000.00
- Revenue This Year
- BBIO $123.32
- OMC $4.63
- Revenue Next Year
- BBIO $73.46
- OMC $3.28
- P/E Ratio
- BBIO N/A
- OMC $10.54
- Revenue Growth
- BBIO 62.46
- OMC 4.13
- 52 Week Low
- BBIO $25.34
- OMC $68.37
- 52 Week High
- BBIO $72.26
- OMC $105.99
- Technical
- Relative Strength Index (RSI)
- BBIO 71.58
- OMC 41.04
- Support Level
- BBIO $64.41
- OMC $71.15
- Resistance Level
- BBIO $67.71
- OMC $75.57
- Average True Range (ATR)
- BBIO 2.80
- OMC 1.82
- MACD
- BBIO 0.35
- OMC 0.07
- Stochastic Oscillator
- BBIO 95.73
- OMC 15.02
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About OMC Omnicom Group Inc.
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, ad placement, and public relations. The firm operates globally, providing services in more than 70 countries; it generates more than one half of its revenue in North America and nearly 30% in Europe.